1 / 6

Spirulina Market Expected to Reach $779 Million by 2026

The increase in penetration of spirulina in the cosmetics and pharmaceutical industries and rise in awareness regarding the benefits of spirulina play a major role in the growth of the spirulina market.

newmarketindustry
Download Presentation

Spirulina Market Expected to Reach $779 Million by 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Spirulina Market

  2. The increase in penetration of spirulina in the cosmetics and pharmaceutical industries and rise in awareness regarding the benefits of spirulina play a major role in the growth of the spirulina market. According to a new report published by Allied Market Research, titled, "Spirulina Market by Type, Application, and Drug Formulation: Global Opportunity Analysis and Industry Forecast, 2019-2026," the global spirulina market generated $348 million in 2018, and is projected to reach $779 million by 2026, growing at a CAGR of 10.5% from 2019 to 2026. The nutraceuticals segment accounted for more than half of the total market share in 2018. Get Sample Report

  3. Spirulina is a filamentous and microscopic cyanobacterium and the name is derived from its spiral or helical filamentous structure. This alga has been used as a source of protein and vitamin supplement in humans without any significant side-effects. It has high content of protein of more than 70% along with vitamins, provitamin A, and minerals, especially iron. Spirulina comprises high anti-oxidant, hypolipidemic, beta-carotene, and anti-inflammatory properties. Owing to exceptional properties, spirulina offers health benefits including reduced cholesterol and blood pressure.

  4. The global spirulina market size has witnessed significant growth in the past few years. The growth in awareness regarding the health benefits of spirulina superfood among consumers and a wide variety of natural colors produced by spirulina contribute toward the market growth. In addition, government of countries such as India and South Africa is promoting the production of spirulina considering its health benefits, which is further expected to boost the spirulina market growth during the forecast period. However, lower stability and poor sustainability of natural colors derived from spirulina as compared to synthetic colors and stringent government regulations are projected to hamper the market growth during the forecast period. Conversely, untapped markets in the developing countries are expected to offer remunerative opportunities for the market players in the near future.

  5. Key Findings of the Spirulina Market : • Based on type, the Arthrospira Maxima segment is expected to experience rapid growth in the market and is projected to grow from 2019 to 2026. • Depending on application, the Nutraceuticals segment holds the highest share in 2018, and is anticipated to continue this trend during the forecast period. • By drug formulation, the powder segment was the major revenue contributor in 2018, and is anticipated to continue this trend during the forecast period. • U.S. generated the highest revenue in the global spirulina market in 2018, accounting for more than one fourth of the global market in 2018. • Asia-Pacific region is estimated to grow at the highest CAGR during the forecast period.

  6. The report provides a comprehensive analysis of the key players operating in the global Spirulina market, namely, Advanced Spirulina, Inc., CAS Medical Systems, Inc., Compumedics Ltd., General Electric Company (GE Healthcare), Koninklijke Philips N.V. (Philips Healthcare), Medtronic Plc., Natus Medical Incorporated, Neural Analytics, Inc., and Siemens AG. The other players in the value chain include GNC Holdings, Inc., Now Health Group Inc, Fuqing King Dnarmsa Spirulina Co., FrakenBiochem Co., Ltd., and Far East Bio-Tec Co. Ltd.

More Related